HomeELVN • NASDAQ
add
Enliven Therapeutics Inc
Previous close
$18.77
Day range
$16.62 - $18.81
Year range
$13.30 - $25.37
Market cap
1.00B USD
Avg Volume
664.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.10M | -7.29% |
Net income | -20.15M | 12.99% |
Net profit margin | — | — |
Earnings per share | -0.32 | 33.08% |
EBITDA | -25.03M | 7.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 477.56M | 63.64% |
Total assets | 490.88M | 60.72% |
Total liabilities | 14.75M | -13.36% |
Total equity | 476.12M | — |
Shares outstanding | 59.35M | — |
Price to book | 2.34 | — |
Return on assets | -12.61% | — |
Return on capital | -12.99% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -20.15M | 12.99% |
Cash from operations | -13.28M | -8.91% |
Cash from investing | -4.06M | -127.37% |
Cash from financing | -368.00K | -132.95% |
Net change in cash | -17.70M | -572.13% |
Free cash flow | -9.01M | 44.06% |
About
Founded
2016
Headquarters
Website
Employees
65
